FDA approves subcutaneous diuretic treatment for heart failure-related edema The U.S. Food and Drug Administration (FDA)has approved another new treatment option for heart-failure related edema HF Collaboratory Muthu Vaduganathan Steve Greene Gregg Fonarow MD BiykemBozkurt Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

Incredible talk on LVAD Alarms by Andrew Higgins at #critcarecards25. High yield for trainees and will be revisiting this many many times: ⭐️ Low flow alarms have a wide differential and they indicate something may be wrong, but it’s our job to think through them carefully

Speaking of cardiac surgeons….next up: “when should you wake up your surgeon for a post op emergency?” By Amy G. Fiedler, MD (Spoiler alert for fellows: I’ve woken up surgeons in Cardiology Fellowship Training at Tufts MC and have never been yelled at!) Onwards …..

In 2014, when I started my first real job as a cardiologist, I didn’t even know how deep in debt I was. After years of deferral and forbearance, the total hit me: $350,000 in student loans, car loans, credit cards, and an underwater condo. My net worth was –$350K at age 32.

Come join us in Tuesday. Beautiful Chicago, with some of my favorite people #CHEST2025 Jean M. Elwing CHEST ATS PC Assembly

In honor of Dr. Robert Bartlett’s passing, here is the first ECMO patient, Esperanza Pineda, both on ECMO shortly after birth in 1975 and at age 44. She is now 50.

This is a truly historic moment. The results from this pivotal trial evaluating a fully percutaneous transcatheter mitral valve replacement technology has opened a new treatment option for patients who are not good candidates for surgery or TEER. This is a remarkable milestone

Thanks so much for the invitation! Very excited to present and meet people at OU College of Medicine !

How I consult on cardiorenal syndrome: • Bump furosemide from 20 to 60 mg bid IV • Consider rapid resumption of sacubitril/valsartan and empagliflozin. Let's not treat these life saving medications as nephrotoxins

Do we need to re-assess how are we treating patients with PAH and methamphetamine use? ATS PC Assembly The Pulmonary Vascular Research Institute CHEST Pulmonary Vascular and Cardiovascular The Pulmonary Hypertension Association UAzPACCS ahajournals.org/doi/10.1161/JA…

Someone needs to listen to this voice of reason Harlan Krumholz JACC Journals because we are the only country that makes practicing as a cardiologist so onerous, expensive, & irrelevant. I do MOC every 3 months & the questions are not helpful to my practice. I leave it to last minute

Check out this great work led by Steven Hsu and team. Generating pressure-volume data and RV-PA coupling with just a PA catheter and in real time is on the horizon! Johns Hopkins Cardiology MUSC Cardiology Duke Cardiology #PeoplesVentricle

1/ 🚨 Just published in Circulation Circulation! Exercise RV–PA coupling predicts adverse outcomes in primary mitral regurgitation (PMR) 💥 We showed that TAPSE/sPAP (measured at VT1; intermediate exercise) is: ✅ Feasible ✅ Prognostic ✅ Validated externally 🧵Thread:

Do we know how inhaled treprostinil works in ILD-PH? Here we show that it’s mainly hemodynamic with exercise CO increasing acutely. But it makes exercise gas exchange worse, and increases exercise PCWP. Complex problem and nightmare to treat in some. publications.ersnet.org/content/erj/ea…

Excellent work by Orly Leiva, MD , our very own Interventional fellow University of Kentucky UK_GillHeart on #PH in patients with myeloproliferative neoplasms at #AHA25 ! #Cardioonc

Outstanding American Heart Association presentation today by MUSC Internal Medicine chief resident Natalie Stringer Dorsey — with simultaneous pub in Journal of Cardiac Failure. Under mentorship of Vishal Rao and in collaboration with Sergio Caravita & #ClaudiaBarrato. Moderate TR matters: worse outcomes, reduced cardiac

POLY-HF trial: Polypill containing metoprolol, spironolactone, and empagliflozin improved EF, QoL, and adherence, and reduced HF hospitalizations at 6 months in HFrEF patients compared to usual care. #AHA25 View the slides here: clinicaltrialresults.org/wp-content/upl…

Panel discussion focusing on the current and future of heart failure care with Nir Uriel, MD MSc Mark Belkin Ryan J Tedford MD Dr. Dan Burkhoff, Dr. Ted Feldman, Mosi Bennett, MD PhD, and Rita Birchard #ChiHemo2025

Session 2 starting out with the most firey 🔥 debate of the year: supine versus upright exercise testing! Chicago Hemodynamic Forum #ChiHemos2025 CardioNerds Check it out~ 👇

We have a few “SimPubs” from the Journal of Cardiac Failure recent Focus Issue on Hemodynamics and the Chicago Hemodynamic Forum #ChiHemos2025 Excellent debate between Marat Fudim, MD MHS and Barry Borlaug Supine is Divine: onlinejcf.com/article/S1071-… Fight for Upright: onlinejcf.com/article/S1071-…